Alzheimers Dement (N Y)
July 2024
Background: In randomized clinical trials (RCTs), monitoring adverse events (AEs) and serious AEs (SAEs) is critical. All Alzheimer's disease (AD) RCTs require participants to enroll with a study partner.
Objective: We examined AE reporting rates in mild-to-moderate AD trials and their associations with study partner type.